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            Elderberry (Sambucus nigra) Shows Promise as a Naturopathic Treatment Against  
Melanoma in vivo and Several Elderberry Fractions Decrease  
Melanoma and Neuroblastoma Cell Proliferation in vitro 
 
 
 
SH-SY5Y Human Neuroblastoma
Treatment 
C
o
n
tr
o
l
1
0
 m
g
/m
l 
E
ld
e
rb
e
rr
y
1
 m
g
/m
l 
E
ld
e
rb
e
rr
y
P
o
o
l 
1
P
o
o
l 
2
P
o
o
l 
3
P
o
o
l 
4
P
o
o
l 
5
P
o
o
l 
6
P
o
o
l 
7
P
o
o
l 
8
P
o
o
l 
9
P
o
o
l 
1
0
P
o
o
l 
1
1
P
o
o
l 
1
2
P
o
o
l 
1
3
P
o
o
l 
1
4
P
o
o
l 
1
5
P
o
o
l 
1
6
P
o
o
l 
1
7
P
o
o
l 
1
8
P
o
o
l 
1
9
P
o
o
l 
2
0
P
o
o
l 
2
1
P
o
o
l 
2
2
P
o
o
l 
2
3
P
o
o
l 
2
4
P
o
o
l 
2
5
P
o
o
l 
2
6
P
o
o
l 
2
7
P
o
o
l 
2
8
P
o
o
l 
2
9
P
o
o
l 
3
0
P
o
o
l 
3
1
P
o
o
l 
3
2
P
o
o
l 
3
3
P
o
o
l 
3
4
P
o
o
l 
3
5
P
o
o
l 
3
6
P
o
o
l 
3
7
P
o
o
l 
3
8
P
o
o
l 
3
9
%
 P
ro
lif
e
ra
ti
o
n
0
.0
0
2
0
.0
0
4
0
.0
0
6
0
.0
0
8
0
.0
0
1
0
0
.0
0
1
2
0
.0
0
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Figure 1. Elderberry (Sambucus nigra) Figure 2. A human melanoma lesion 
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Figure 3. The Effect of Daily Elderberry Treatment on Melanoma Tumor Size. 
(Left Panel) Control and Elderberry treated mouse tumor weights after 14 days 
preventative treatments and 7 days post-cancer challenge treatments .(Upper Right 
Panel) A control mouse with a visible melanoma tumor. (Lower Right Panel) A 
metastatic tumor dissected from a control mouse. 
 Melanoma causes an estimated 71-80% of skin cancer deaths due to 
its aggressive metastatic nature in late stages of the disease. Incidence 
rates of melanoma continue to grow annually, suggesting the need for 
preventative anti-melanoma research.  
 
 Naturally occurring dark-pigmented berries may have such cancer-
inhibiting properties. There is evidence that elderberry extracts can be 
incorporated into endothelial cells to protect against oxidative stress1 and 
stimulate an immune response that may suppress tumor growth2. 
 
 Our goal is to identify active elderberry fractions capable of 
modulating proliferation of melanoma both in vivo and in vitro, and to 
assess the ubiquity of fraction activity in other cancer cell lines. Proper 
identification of tumor-suppressing elderberry fractions may lead to diet-
based strategies for the prevention of many cancers, including melanoma. 
 C57BL/6J mice were randomly grouped into a water treated (control) 
group and an elderberry (10 mg/mL) treated group. Mice were given daily 
0.5 mL i.p. treatment injections for 14 days before s.c. injection of 1 x 105 
B16-F10 murine melanoma cells to the right flank. Treatments were 
continued up to day 21 and mice were sacrificed on day 27. 
 
 Column Chromatography was used to separate the components of 
elderberry powder. Fractions were evaporated dry and re-dissolved in 0.5 
mL PBS. Neighboring active fractions were pooled. 
 
 Human melanoma (MeWo), murine melanoma (B16-F10) and human 
neuroblastoma (SH-SY5Y) cells were treated with 10 µL crude and pooled 
fraction treatments at 24 hours. Cells were tagged with 1 mCi/mL 
radioactive tritiated thymidine at 48 hours and were harvested and counted 
at 72 hours.  
Figure 5. Proliferation Assay of Different Cancer Cell Lines. (Left Panel) B16-F10 
cells and (Right Panel) SH-SY5Y cells were treated with 10 µL crude elderberry 
(10mg/mL and 1mg/mL) or pooled  elderberry fraction.  The percent proliferation of 
elderberry treated cells was based on growth of control cells at 100%.  
Figure 4. Proliferation Assay of Human Melanoma Cells. MeWo cells were 
treated with 10 µL crude elderberry (10mg/mL and 1mg/mL) or pooled  elderberry 
fraction.  The percent proliferation of elderberry treated cells was based on growth of 
control cells at 100%.  
We would like to thank Artemis International Inc. (Fort Wayne, IN) and the 
IPFW Chemistry Department for use of their supplies and equipment.  
 On average, control mice had larger tumors than elderberry-treated 
mice in vivo (2.88 g vs. 0.54 g, respectively). 
• 67% of control tumors metastasized (vs. 0% elderberry-treated) 
 
 Pooled elderberry fractions significantly (*) decreased proliferation 
of multiple cancer cell lines in vitro. 
• 72% of pooled fractions decreased MeWo growth by 20% or more 
• 100% of pooled fractions decreased B16-F10 growth by 40% or more 
• 100% of pooled fractions decreased SH-SY5Y growth by 20% or more 
  
 These results suggest that elderberry fractions may be useful in a 
naturopathic strategy to suppress multiple cancers and validates further 
study. Future experiments should aim to determine the chemical  
identity of active fractions and the cellular mechanisms by which they 
operate to inhibit tumor growth. 
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